Published in J Cardiovasc Pharmacol Ther on January 21, 2009
Update on statin-mediated anti-inflammatory activities in atherosclerosis. Semin Immunopathol (2009) 1.04
Targeting stem cell niches and trafficking for cardiovascular therapy. Pharmacol Ther (2010) 0.95
Race differences: modeling the pharmacodynamics of rosuvastatin in Western and Asian hypercholesterolemia patients. Acta Pharmacol Sin (2010) 0.83
Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs. Eur J Clin Pharmacol (2009) 0.81
Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease. Stem Cell Res Ther (2015) 0.81
Effects of a nutraceutical combination on lipids, inflammation and endothelial integrity in patients with subclinical inflammation: a randomized clinical trial. Sci Rep (2016) 0.75
Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens (2012) 3.73
The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) (2006) 3.03
Ambulatory arterial stiffness index is not a specific marker of reduced arterial compliance. Hypertension (2007) 2.93
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension (2007) 2.90
Short- and long-term incidence of stroke in white-coat hypertension. Hypertension (2004) 2.58
Ambulatory arterial stiffness index: merits and limitations of a simple surrogate measure of arterial compliance. J Hypertens (2008) 1.66
Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. Arterioscler Thromb Vasc Biol (2005) 1.57
Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans. Circulation (2009) 1.56
Prognostic significance of isolated, non-specific left ventricular repolarization abnormalities in hypertension. J Hypertens (2004) 1.56
Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol (2004) 1.47
Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension (2012) 1.47
Heritability of central blood pressure and arterial stiffness: a twin study. J Hypertens (2012) 1.45
Prognostic impact of prolonged ventricular repolarization in hypertension. Arch Intern Med (2006) 1.44
Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study. Am J Hypertens (2007) 1.43
Combined effects of office and 24-h blood pressure on aortic stiffness in human hypertension. J Hypertens (2011) 1.43
Pressure-independent relationship of aortic characteristic impedance with left ventricular mass and geometry in untreated hypertension. J Hypertens (2015) 1.43
Decreasing cardiovascular risk in HIV infection between 2005 and 2011. AIDS (2014) 1.39
Are observational studies more informative than randomized controlled trials in hypertension? Con side of the argument. Hypertension (2013) 1.38
CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation (2004) 1.36
Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure. J Hypertens (2013) 1.36
Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol (2006) 1.36
Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol (2002) 1.31
Precocious intima-media thickening in patients with primary Sjögren's syndrome. Arthritis Rheum (2005) 1.25
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol (2005) 1.19
Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward. J Clin Microbiol (2012) 1.19
Serum 25-hydroxyvitamin D concentration in subclinical carotid atherosclerosis. Arterioscler Thromb Vasc Biol (2013) 1.18
Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study. Eur Heart J (2009) 1.17
Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr (2007) 1.15
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol (2012) 1.14
Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension (2006) 1.13
The first statement of the Working Group on Electrocardiographic Diagnosis of Left Ventricular Hypertrophy. J Electrocardiol (2010) 1.12
Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. J Hypertens (2007) 1.10
Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. Hypertension (2008) 1.09
Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressures. J Hypertens (2003) 1.08
Metabolic syndrome is associated with aortic stiffness in untreated essential hypertension. Hypertension (2005) 1.07
Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res (2008) 1.05
Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women. Metabolism (2004) 1.03
Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Ann N Y Acad Sci (2005) 1.01
Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study. J Infect (2008) 1.00
Relation between renal function within the normal range and central and peripheral arterial stiffness in hypertension. Hypertension (2006) 1.00
High weight or body mass index increase the risk of vertebral fractures in postmenopausal osteoporotic women. J Bone Miner Metab (2009) 0.99
Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors. Ann N Y Acad Sci (2007) 0.99
Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis (2007) 0.97
Age-specific relationship of aortic pulse wave velocity with left ventricular geometry and function in hypertension. Hypertension (2007) 0.97
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. J Am Coll Cardiol (2002) 0.97
Is estimated cardiovascular risk higher in HIV-infected patients than in the general population? Scand J Infect Dis (2007) 0.95
Progression of carotid intima-media thickness as predictor of vascular events: results from the IMPROVE study. Arterioscler Thromb Vasc Biol (2013) 0.95
Functional impairment of the arterial wall in primary Sjögren's syndrome: combined action of immunologic and inflammatory factors. Arthritis Care Res (Hoboken) (2010) 0.94
Insulin resistance and not BMI is the major determinant of early vascular impairment in patients with morbid obesity. J Atheroscler Thromb (2013) 0.93
Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis (2011) 0.92
Identification of the BCAR1-CFDP1-TMEM170A locus as a determinant of carotid intima-media thickness and coronary artery disease risk. Circ Cardiovasc Genet (2012) 0.92
Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease. Atherosclerosis (2005) 0.90
Renal denervation for resistant hypertension. N Engl J Med (2014) 0.90
Capillary rarefaction and abnormal cardiovascular reactivity in hypertension. J Hypertens (2003) 0.90
Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia. Nutr Metab Cardiovasc Dis (2006) 0.90